• call for care 214.379.2700

    Choice Cancer Care is here for you 9AM – 5PM Monday – Friday

    Inquiring after hours? Complete our contact form and we will be in touch as soon as possible.

    Call

  • Patientportal

    Access Your Portal To Health at Choice Cancer Care.

    Learn more about becoming a CCC Patient, including insurance information and patient rights, or login to access your personal portal for in-depth information about your health.

    LoginSign UpLearn More

  • get a second opinion

    Recent Diagnosis? Gain Confidence With A Second Opinion.

    Find out what to ask your doctor, what a second opinion could mean for you, and take the steps to get you on the right path to treat your cancer.

    Complete this form for a no obligation consultation:







    captcha

  • certified

    Choice Cancer Care is proud to be recognized by the Quality Oncology Practice Initiative (QOPI®) for excellence in quality, and safety in the administration of cancer care.

    Learn More

New Drug Shows Great Promise in Treating Lung Cancer

It is estimated that more than 200,000 people are diagnosed with lung cancer each year in the United States. Some 160,000 people die from this disease annually across the country. With those grim numbers in mind, researchers work around the clock devising new methods for detection and treatment. A new breakthrough in the treatment department is shedding a ray of hope for those who treat this disease with many calling it “transformative.”

The new breakthrough involves the use of a drug called Keytruda. While still in its testing phases, Keytruda has gone through clinical trials with incredibly promising results.

Keytruda works in a different way than standard cancer-killing drugs. Rather than seek out and destroy cells like standard chemotherapy drugs, Keytruda, aims to get the body to do the dirty work on its own.

Cancer is known to suppress the immune system, but Keytruda is designed to stop communication between cancer cells and key proteins. This essentially enables the body’s own natural immune system to kick in and start doing its job. Some patients involved in the clinical trial have watched as, over time, Keytruda has dramatically reduced tumor size on their lungs and in areas where the disease spread.

While full FDA approval for Keytruda is still pending, the agency has assigned a priority review. The drug can be used for patients who have advanced non-small cell lung cancer. A final decision is hoped to arrive on October, allowing for more widespread use in treating lung cancer.

Keytruda isn’t just showing itself effective for treating lung cancer either. The FDA has already approved its use for melanoma and data suggests it could be helpful in treating kidney, bladder and some breast cancers, as well. Studies in relation to the drug’s effects on these types of cancer are already under way.

People who are concerned about lung cancer are urged to speak with their healthcare providers. This disease if caught early can be treated effectively in some cases. Exact treatment options will hinge on a person’s unique case.

It is estimated that more than 200,000 people are diagnosed with lung cancer each year in the United States. Some 160,000 people die from this disease annually across the country. With those grim numbers in mind, researchers work around the clock devising new methods for detection and treatment. A new breakthrough in the treatment department is shedding a ray of hope for those who treat this disease with many calling it “transformative.”

The new breakthrough involves the use of a drug called Keytruda. While still in its testing phases, Keytruda has gone through clinical trials with incredibly promising results.

Keytruda works in a different way than standard cancer-killing drugs. Rather than seek out and destroy cells like standard chemotherapy drugs, Keytruda, aims to get the body to do the dirty work on its own.

Cancer is known to suppress the immune system, but Keytruda is designed to stop communication between cancer cells and key proteins. This essentially enables the body’s own natural immune system to kick in and start doing its job. Some patients involved in the clinical trial have watched as, over time, Keytruda has dramatically reduced tumor size on their lungs and in areas where the disease spread.

While full FDA approval for Keytruda is still pending, the agency has assigned a priority review. The drug can be used for patients who have advanced non-small cell lung cancer. A final decision is hoped to arrive on October, allowing for more widespread use in treating lung cancer.

Keytruda isn’t just showing itself effective for treating lung cancer either. The FDA has already approved its use for melanoma and data suggests it could be helpful in treating kidney, bladder and some breast cancers, as well. Studies in relation to the drug’s effects on these types of cancer are already under way.

People who are concerned about lung cancer are urged to speak with their healthcare providers. This disease if caught early can be treated effectively in some cases. Exact treatment options will hinge on a person’s unique case.

Cancer Screening Guidelines

Screening can help doctors discover and treat some types of cancer early. Usually, cancer treatment is more effective when the disease is detected in its early stages and there could be a better chance of curing the cancer. Some...

Learn More

Save Your Hair During Chemo

We offer the Chemo Cold Caps Solution for patients seeking to save their hair while undergoing chemotherapy.  The Chemotherapy Cold Caps program can be accessed at any of our North Texas clinics. At Choice Cancer Care we know that being diagnosed with...

Learn More

Learn About Your Options

Your journey with cancer is influenced by several factors. These factors include your overall condition, the specific characteristics of your cancer, and whether the goal of treatment is to eradicate your cancer, stop your cancer from spreading to other areas...

Learn More